The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C01 | Cardiac therapy | |
| 3 | C01C | Cardiac stimulants excl. cardiac glycosides | |
| 4 | C01CA | Adrenergic and dopaminergic agents | |
| 5 | C01CA27 |
| Active Ingredient | Description | |
|---|---|---|
| Droxidopa |
Droxidopa is a synthetic amino acid analog that is directly metabolized to norepinephrine by dopa-decarboxylase, which is extensively distributed throughout the body. Droxidopa is believed to exert its pharmacological effects through norepinephrine and not through the parent molecule or other metabolites. The exact mechanism of action of droxidopa in the treatment of neurogenic orthostatic hypotension is unknown. |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
